Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphanie Guidez

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Cancers|October 14, 2020
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020Arthur Bobin, Evelyne Liuu, Niels Moya, et al.
Blood Advances|September 21, 2022
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazineAntoine Machet, Caroline Poudou, Cécile Tomowiak, et al.
Cancer|August 8, 2013
Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myelomaGuillemette Fouquet, Stéphanie Tardy, Hélène Demarquette, et al.
Blood Cancer Journal|November 3, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trialsValentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, et al.
Haematologica|April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA studyAxel André, Estelle Bourbon, Guillaume Cartron, et al.
Annals of Hematology|March 5, 2024
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE studyCaroline Dartigeas, Anne Quinquenel, Loïc Ysebaert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myelomaGuillemette Fouquet, Stéphanie Guidez, Charles Herbaux, et al.
Blood Advances|September 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA GroupMarion Aymard, Morgane Cheminant, Roch Houot, et al.
Frontiers in Physiology|April 4, 2017
Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple MyelomaFelicity Kendrick, Neil D Evans, Bertrand Arnulf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
<i>TP53</i> Mutation and Its Prognostic Significance in Waldenstrom's MacroglobulinemiaStéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Cancers|October 14, 2020
Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020Arthur Bobin, Evelyne Liuu, Niels Moya, et al.
Blood Advances|September 21, 2022
Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazineAntoine Machet, Caroline Poudou, Cécile Tomowiak, et al.
Cancer|August 8, 2013
Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myelomaGuillemette Fouquet, Stéphanie Tardy, Hélène Demarquette, et al.
Blood Cancer Journal|November 3, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trialsValentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, et al.
Haematologica|April 9, 2026
Anti-CD19 CAR T-cell therapy in relapsed/refractory T-cell/histiocyte-rich large B-cell lymphoma: insights from the French DESCAR-T registry, a LYSA studyAxel André, Estelle Bourbon, Guillaume Cartron, et al.
Annals of Hematology|March 5, 2024
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE studyCaroline Dartigeas, Anne Quinquenel, Loïc Ysebaert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myelomaGuillemette Fouquet, Stéphanie Guidez, Charles Herbaux, et al.
Blood Advances|September 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA GroupMarion Aymard, Morgane Cheminant, Roch Houot, et al.
Frontiers in Physiology|April 4, 2017
Analysis of a Compartmental Model of Endogenous Immunoglobulin G Metabolism with Application to Multiple MyelomaFelicity Kendrick, Neil D Evans, Bertrand Arnulf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
<i>TP53</i> Mutation and Its Prognostic Significance in Waldenstrom's MacroglobulinemiaStéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, et al.
Pageof 6